This article is more than 5 years old. Information may no longer be current.
Five Top Stories From the Biologic Therapies VII Summit
Click Here to Manage Email Alerts
Healio Rheumatology features the top stories from the Biologic Therapies VII Summit. More of Healio Rheumatology’s live coverage, including video interviews with researchers, can be found by clicking here.
Ritchlin reviews treatments for psoriatic arthritis, ankylosing spondylitis
CLEVELAND — Christopher Ritchlin, MD, MPH, professor of medicine at the University of Rochester Medical Center, reviewed treatments for psoriatic arthritis, spondyloarthritis and other spondyloarthropathies at the Primary Vasculitides Pre-symposium of the Biologic Therapies VII Summit. Read More.
Langford: Conventional therapy still has a role in granulomatosis with polyangiitis, microscopic polyangiitis
CLEVELAND — Conventional therapy still has a role in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis; however, there are many factors that need to be examined for each patient, Carol A. Langford, MD, MHS, director for Vasculitis Care and Research in the Department of Rheumatic and Immunologic Diseases at the Cleveland Clinic, said in her presentation at the Primary Vasculitides Pre-symposium of the Biologic Therapies VII Summit. Read More.
Kay reviews role of biomarkers in the prediction of RA outcomes
CLEVELAND — At the Biologic Therapies VII Summit, Jonathan Kay, MD, professor of medicine at the University of Massachusetts Medical School, reviewed the role of biomarkers in predicting outcomes for patients with rheumatoid arthritis (RA). Read More.
Calabrese details prevention of serious infections in patients with immune-mediated inflammatory diseases
CLEVELAND — At the Biologic Therapies VII Summit, Leonard Calabrese, DO, professor of medicine at the Cleveland Clinic and Chief Medical Editor of Healio Rheumatology, described how to prevent serious infections in patients with immune-mediated inflammatory diseases. Read More.
Specks describes unmet needs in management of granulomatosis with polyangiitis, microscopic polyangiitis
CLEVELAND — At the Primary Vasculitides Pre-symposium of the Biologic Therapies VII Summit, Ulrich Specks, MD, professor of medicine at the Mayo Clinic College of Medicine, described unmet needs in the management of granulomatosis with polyangiitis and microscopic polyangiitis. Read More.
Collapse
Read more about
Click Here to Manage Email Alerts